General Information of the Compound
| Compound ID |
CP0551381
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[(2S,5S,8S,11S,14S,17R)-2,8-bis(4-aminobutyl)-11-[3-(carbamoylamino)propyl]-17-(hydroxymethyl)-14-(2-methylpropyl)-3,6,9,12,15,19-hexaoxo-1,4,7,10,13,16-hexazacyclononadec-5-yl]acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H58N10O10
|
||||||||||||||||||
| Molecular Weight |
742.876
|
||||||||||||||||||
| Canonical SMILES |
CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](CO)NC1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H58N10O10/c1-18(2)14-23-30(50)37-19(17-43)15-25(44)38-20(8-3-5-11-33)27(47)42-24(16-26(45)46)31(51)40-21(9-4-6-12-34)28(48)39-22(29(49)41-23)10-7-13-36-32(35)52/h18-24,43H,3-17,33-34H2,1-2H3,(H,37,50)(H,38,44)(H,39,48)(H,40,51)(H,41,49)(H,42,47)(H,45,46)(H3,35,36,52)/t19-,20+,21+,22+,23+,24+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BHGCMOZGMXWXQJ-CKOZHMEPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound